Skip to main content

Table 1 Study characteristics of included trials

From: Level of daily physical activity in individuals with COPD compared with healthy controls

Reference

N (P/C)

Mean Age (yrs±SD, P;C)

Gender (Male/Female) (P/C)

Variation in GOLD stage

Measurement device

Duration of study (days)

Coronado (2003)

25 (15/10)

67 ± 9; 57 ± 5

13:2; 4:6

1-4

Uni-axial accelerometer

1

Hernandes (2009)

70 (40/30)

66 ± 8;64 ± 7

18:22; 14:16

2-4

Tri-axial accelerometer

2

Lores (2006)

35 (23/12)

62 ± 7; 59 ± 7

20:3; 9:3

2-4

Tri-axial accelerometer

3

Pitta (2005)

75 (50/25)

64 ± 7; 66 ± 5

36:14; 17:8

1-4

Tri-axial accelerometer

2

Pitta (2008)

40

68 ± 7

21:19

1-4

Multisensor armband

2

Sandland (2005)

20 (10/10)

nd

nd

3

Uni-axial accelerometer

7

Schönhofer (1997)

50 (25/25)

56 ± 12; 53 ± 14

14:11; 14:11

2-3

Pedometer

7

Singh (2001)

20 (11/9)

66 ± 9; 59 ± 4

7:4; 5:4

3

Uni-axial accelerometer

2

Steele (2000)

47

66 ± 8

44:3

1-4

Tri-axial accelerometer

3

Steele (2003)

63

nd

nd

nd

Accelerometer

3

Troosters (2010)

100 (70/30)

66 ± 9; 65 ± 7

58:12; 19:11

1-4

Multisensor armband

6-8

Walker (2008)

51 (33/18)

67 ± 8; 70 ± 6

17:16; 8:10

3

Uni-axial accelerometer

3

Watz (2008)

170

64 ± 6.6

128:42

1-4

Multisensor armband

5-6

  1. N = number of subjects, P = patients, C = controls, yrs = years, SD = standard deviation, nd = not described.